Oct 30, 2023 | Publications
A new antibody has been developed to target Neuropilin-2 (NRP2), a receptor involved in processes like lymphangiogenesis, cancer, and inflammation. This antibody, unlike existing ones, is specifically designed for companion diagnostics. Tests using various methods...